351 related articles for article (PubMed ID: 16542442)
1. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy.
Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M
BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442
[TBL] [Abstract][Full Text] [Related]
2. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of a child with t(15;19)-positive tumor.
Mertens F; Wiebe T; Adlercreutz C; Mandahl N; French CA
Pediatr Blood Cancer; 2007 Dec; 49(7):1015-7. PubMed ID: 16435379
[TBL] [Abstract][Full Text] [Related]
4. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.
Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H
Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834
[TBL] [Abstract][Full Text] [Related]
5. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
[TBL] [Abstract][Full Text] [Related]
6. Midline carcinoma of children and young adults with NUT rearrangement.
French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA
J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023
[TBL] [Abstract][Full Text] [Related]
7. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
Cassinat B; Guillemot I; Moluçon-Chabrot C; Zassadowski F; Fenaux P; Tournilhac O; Chomienne C
Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
[TBL] [Abstract][Full Text] [Related]
8. NUT midline carcinoma: an aggressive intrathoracic neoplasm.
Parikh SA; French CA; Costello BA; Marks RS; Dronca RS; Nerby CL; Roden AC; Peddareddigari VG; Hilton J; Shapiro GI; Molina JR
J Thorac Oncol; 2013 Oct; 8(10):1335-8. PubMed ID: 24457244
[TBL] [Abstract][Full Text] [Related]
9. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19).
French CA; Miyoshi I; Aster JC; Kubonishi I; Kroll TG; Dal Cin P; Vargas SO; Perez-Atayde AR; Fletcher JA
Am J Pathol; 2001 Dec; 159(6):1987-92. PubMed ID: 11733348
[TBL] [Abstract][Full Text] [Related]
10. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.
French CA; Miyoshi I; Kubonishi I; Grier HE; Perez-Atayde AR; Fletcher JA
Cancer Res; 2003 Jan; 63(2):304-7. PubMed ID: 12543779
[TBL] [Abstract][Full Text] [Related]
11. NUT midline carcinoma of the parotid gland with mesenchymal differentiation.
den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ
Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446
[TBL] [Abstract][Full Text] [Related]
12. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
[TBL] [Abstract][Full Text] [Related]
13. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.
Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O
J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174
[TBL] [Abstract][Full Text] [Related]
14. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
[TBL] [Abstract][Full Text] [Related]
15. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
16. Successful radical treatment of midline carcinoma with t(15;19) diagnosed by endobronchial ultrasound-derived transbronchial needle aspiration.
Santis G; Landau D; Harrison-Phipps K; Neat M; Moonim MT
J Clin Oncol; 2011 Apr; 29(12):e327-9. PubMed ID: 21263093
[No Abstract] [Full Text] [Related]
17. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F
Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
[No Abstract] [Full Text] [Related]
18. NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic/hepatic primary.
Shehata BM; Steelman CK; Abramowsky CR; Olson TA; French CA; Saxe DF; Ricketts RR; Katzenstein HM
Pediatr Dev Pathol; 2010; 13(6):481-5. PubMed ID: 20017639
[TBL] [Abstract][Full Text] [Related]
19. Nuclear protein in testis midline carcinoma with unusual elevation of α-fetoprotein and synaptophysin positivity: a case report and review of the literature.
Raza A; Cao H; Conrad R; Cobb C; Castelino-Prabhu S; Mirshahidi S; Shiraz P; Mirshahidi HR
Expert Rev Anticancer Ther; 2015; 15(10):1199-213. PubMed ID: 26402248
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
